KBPH On Other Exchanges
text size: T | T
Back to Snapshot
Company Description

Contact Info

500 Australian Avenue South

Suite 600

West Palm Beach, FL 33401

United States

Phone: 416-960-8790


Kyto Biopharma, Inc., a biopharmaceutical company, acquires and develops minimally toxic and non-immunosuppressive proprietary drugs for the treatment of cancer, arthritis, and other proliferate and autoimmune diseases. History The company was founded in 1999. It was incorporated as a Florida corporation in 1999. The company was formerly known as B Twelve, Inc. and changed its name to Kyto Biopharma, Inc. in 2002.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

KBPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KBPH.
View Industry Companies

Industry Analysis


Industry Average

Valuation KBPH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KYTO BIOPHARMA INC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.